17 results
424B4
SILO
SILO Pharma Inc
28 Sep 22
Prospectus supplement with pricing info
4:34pm
of its transparency initiative, is currently considering whether to make additional information publicly available on a routine basis, including … transparency by making the following amendments to the disclosure for convertible instruments:
Add a disclosure objective
Add information about events
424B3
5rpf o6dk9cav
13 Apr 21
Prospectus supplement
6:02am
424B3
96awpm
20 Oct 20
Prospectus supplement
11:02am
8-K
j1w 4c5yc6jz8a
20 Oct 20
Regulation FD Disclosure
9:41am
- Prev
- 1
- Next